miR182 activates the Ras–MEK–ERK pathway in human oral cavity squamous cell carcinoma by suppressing RASA1 and SPRED1

miR182 activates the Ras–MEK–ERK pathway in human oral cavity squamous cell carcinoma by suppressing RASA1 and SPRED1

Jinhui Wang,1,* Wei Wang,2,* Jichen Li,2 Liji Wu,2 Mei Song,1 Qinggang Meng3 1Department of Clinical Laboratory, Harbin First Hospital, 2Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Harbin Medical University, 3Department of Osteological Surgery, Harbin Fir...

Full description

Bibliographic Details
Main Authors: Wang JH, Wang W, Li JC, Wu LJ, Song M, Meng QG
Format: Article
Language:English
Published: Dove Medical Press 2017-02-01
Series:OncoTargets and Therapy
Subjects:
miR-182
RAS-MEK-ERK
RASA1
SPRED1
OSCC
Online Access:https://www.dovepress.com/mir182-activates-the-rasndashmekndasherk-pathway-in-human-oral-cavity--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/mir182-activates-the-rasndashmekndasherk-pathway-in-human-oral-cavity--peer-reviewed-article-OTT

Similar Items